Skip to main content

Thermo Fisher to Distribute Innovative Biosensors' Pathogen Test

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will manufacture and distribute a multiplex pathogen-detection test for Innovative Biosensors under an agreement announced Tuesday.

Specifically, the Thermo Fisher Air Quality Instruments business will manufacture IB's BioFlash Biological Aerosol Collection, Detection and Identification System. The multiplex test detects up to 21 pathogens in real-time. In addition, Thermo Fisher has a worldwide sales, marketing, and distribution license under the Thermo Scientific brand in certain markets for BioFlash and associated consumables.

Financial terms of the collaboration were not disclosed.

"Thermo Fisher's world class manufacturing capabilities will enable us to satisfy the growing market demand for the BioFlash, which offers the unique capability of sampling, collecting, and identifying airborne pathogens in three minutes," Joe Hernandez, IB President and CEO, said in a statement.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.